
أَكَادِيمِيَّةُ أَلْإِحْسَانِ لِلْقُرْأَنِ وَأَلْعُلُومِ أَلشَّرْعِيَّةِ
48343 Reviews
40854 Posts
قناة التلجرام
https://www.tg-me.com/joinchat-VIaRT1ONL5GpicuU
البوت الخاص بأكاديمية الإحسان
@ihsanacademybot
"لا ينال العلم براحة الجسم"
أَكَادِيمِيَّةُ أَلْإِحْسَانِ لِلْقُرْأَنِ وَأَلْعُلُومِ أَلشَّرْعِيَّةِ
tg-me.com/joinchat-VIaRT1ONL5GpicuU
أَكَادِيمِيَّةُ أَلْإِحْسَانِ لِلْقُرْأَنِ وَأَلْعُلُومِ أَلشَّرْعِيَّةِ Telegram | DID YOU KNOW?
Spiking bond yields driving sharp losses in tech stocks
A spike in interest rates since the start of the year has accelerated a rotation out of high-growth technology stocks and into value stocks poised to benefit from a reopening of the economy. The Nasdaq has fallen more than 10% over the past month as the Dow has soared to record highs, with a spike in the 10-year US Treasury yield acting as the main catalyst. It recently surged to a cycle high of more than 1.60% after starting the year below 1%. But according to Jim Paulsen, the Leuthold Group's chief investment strategist, rising interest rates do not represent a long-term threat to the stock market. Paulsen expects the 10-year yield to cross 2% by the end of the year. A spike in interest rates and its impact on the stock market depends on the economic backdrop, according to Paulsen. Rising interest rates amid a strengthening economy "may prove no challenge at all for stocks," Paulsen said.
أَكَادِيمِيَّةُ أَلْإِحْسَانِ لِلْقُرْأَنِ وَأَلْعُلُومِ أَلشَّرْعِيَّةِ from ARSouth Africa SA telegram Group & telegram Channel 10
Telegram أَكَادِيمِيَّةُ أَلْإِحْسَانِ لِلْقُرْأَنِ وَأَلْعُلُومِ أَلشَّرْعِيَّةِ

Created:
From: ARGENTINA and South Africa
Telegram أَكَادِيمِيَّةُ أَلْإِحْسَانِ لِلْقُرْأَنِ وَأَلْعُلُومِ أَلشَّرْعِيَّةِ, 753821 Telegram Group & Telegram Channel ARGENTINA, SATelegram أَكَادِيمِيَّةُ أَلْإِحْسَانِ لِلْقُرْأَنِ وَأَلْعُلُومِ أَلشَّرْعِيَّةِ, 753821 Telegram Group & Telegram Channel, South Africa,
TG أَكَادِيمِيَّةُ أَلْإِحْسَانِ لِلْقُرْأَنِ وَأَلْعُلُومِ أَلشَّرْعِيَّةِ
https://t.me/joinchat/VIaRT1ONL5GpicuU